1. Home
  2. CVRX vs HYPR Comparison

CVRX vs HYPR Comparison

Compare CVRX & HYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CVRx Inc.

CVRX

CVRx Inc.

HOLD

Current Price

$5.63

Market Cap

139.3M

Sector

Health Care

ML Signal

HOLD

Logo Hyperfine Inc.

HYPR

Hyperfine Inc.

HOLD

Current Price

$1.27

Market Cap

158.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CVRX
HYPR
Founded
2000
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
139.3M
158.8M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
CVRX
HYPR
Price
$5.63
$1.27
Analyst Decision
Buy
Strong Buy
Analyst Count
4
4
Target Price
$10.50
$1.59
AVG Volume (30 Days)
311.6K
1.6M
Earning Date
05-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
23.02
23.21
EPS
N/A
N/A
Revenue
$56,651,000.00
$13,563,000.00
Revenue This Year
$17.17
$50.75
Revenue Next Year
$17.69
$29.71
P/E Ratio
N/A
N/A
Revenue Growth
10.45
5.22
52 Week Low
$4.37
$0.76
52 Week High
$11.30
$2.22

Technical Indicators

Market Signals
Indicator
CVRX
HYPR
Relative Strength Index (RSI) 52.44 39.37
Support Level $5.06 $1.03
Resistance Level $5.99 $1.39
Average True Range (ATR) 0.39 0.13
MACD 0.12 -0.02
Stochastic Oscillator 70.87 2.25

Price Performance

Historical Comparison
CVRX
HYPR

About CVRX CVRx Inc.

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

About HYPR Hyperfine Inc.

Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales, which consist of sales from subscriptions of bundled devices, maintenance, and software. The company is in the health technology business with a mission to revolutionize patient care globally through accessible, affordable, clinically relevant artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. The Company operates in one business segment, which includes all activities related to production, supply, service, and commercialization of the Swoop system.

Share on Social Networks: